BMY Bristol Myers Squibb

Bristol-Myers Squibb Co is engaged in discovery, development, licensing, manufacturing, marketing, distribution and sale of pharmaceuticals and nutritional products. The company operates in two segments namely Pharmaceuticals and Nutritionals.

$62.61  +0.70 (1.13%)
As of 04/09/2021 16:00:02 EST     IEX book   CBOE book


Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Large cap
GICS sector:  Health Care
Industry:  Drug Manufacturers—General
Index country:  USA
Country of incorporation:  USA
IPO date:  02/09/2001
Outstanding shares:  2,233,927,936
Average volume:  11,543,377
Market cap:   $139,866,228,073
Current dividend yield:  2.97%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    110122108
ISIN:        US1101221083
Sedol:      2126335
Valuation   (See tab for details)
PE ratio:   -15.51
PB ratio:   3.71
PS ratio:   3.29
Return on equity:   -23.84%
Net income %:   -21.20%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy